Show simple item record

dc.contributor.author Wymer, Walter
dc.date.accessioned 2018-12-17T03:37:39Z
dc.date.available 2018-12-17T03:37:39Z
dc.date.issued 2008
dc.identifier.citation Wymer, W. (2008). A macromarketing analysis of prescription drugs in the U.S. Journal of Research for Consumers, 14, 1-19. Retrieved from http://jrconsumers.com/academic_articles/issue_14/Macromarketing_academic.pdf en_US
dc.identifier.uri https://hdl.handle.net/10133/5260
dc.description Open access; available under the CC BY 4.0 license en_US
dc.description.abstract The U.S. prescription drug macromarketing system is examined. Over time, this system has become unbalanced. The system has evolved into one in which market competition has been restricted. This market system now has substantial entry barriers, producer collusion, and extensive linkages between producers and government resulting in government protection of producers. Suggested reforms are offered which aim to bring into greater harmony the interests of both producers and society, while acknowledging the importance of prescription drugs to society and maintaining producer incentives to invest in research and development of innovative new drugs. en_US
dc.language.iso en_US en_US
dc.publisher Journal of Research for Consumers en_US
dc.subject Macromarketing system en_US
dc.subject Market systems en_US
dc.subject Market competition en_US
dc.subject Prescription drugs en_US
dc.subject Drug companies en_US
dc.subject Marketing system en_US
dc.subject.lcsh Drugs--Marketing--United States
dc.subject.lcsh Drug development--United States
dc.subject.lcsh Drugs--Law and legislation--United States
dc.title A macromarketing analysis of prescription drugs in the U.S. en_US
dc.type Article en_US
dc.publisher.faculty Management en_US
dc.description.peer-review Yes en_US
dc.publisher.institution University of Lethbridge en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record